Home/ Supplements/ Colostrum/ Candida Control

Candida Control

product on market Capsule BIOVEA Safety: 90/100
90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • Limited research evidence available for ingredients
B Label Compliance Grade
Alerts

Safety Alerts

Contains proprietary blend — exact ingredient amounts not disclosed

Label

Product Label

Label for Candida Control
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
60
Servings
Non-Nutrient/Non-Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 800.0mg (172 products)
Proprietary Blend
240 mg
Lactoferrin
28 mg

Other Ingredients

Rice Starch Gelatin Capsules
Claims

Label Claims — Verification

Unverified No Claim
Info

Product Information

Directions for Use

Suggested Daily Intake: Adults: Take 2 capsules, twice daily on an empty stomach. Take 6 capsules twice daily in times of environmental or physical stress.

Additional Information

guaranteed premium quality

yeast management complex

Metadata

Product Details

UPC / SKU6 89076 04317 5
DSLD Entry Date2014-06-25
Product TypeNon-Nutrient/Non-Botanical
FormCapsule
BrandBIOVEA
DSLD ID34377
Data Updated2026-04-11
Research

Research Evidence

19
Research Sources
52
Avg Quality
8
Clinical Trial
4
Cochrane Review
2
Systematic Review
2
Meta Analysis
2
Guideline
1
Rct
B [Expert consensus on the application of intravenous immunoglobulin in children with autoimmune neurological disorders (2025)].
Guideline Zhonghua er ke za zhi = Chinese journal of pediatrics 2025 PubMed DOI
B Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV).
Guideline Kidney international 2025 PubMed DOI
B Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain Barré syndrome.
Cochrane Review The Cochrane database of systematic reviews PubMed DOI
B Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.
Cochrane Review The Cochrane database of systematic reviews PubMed DOI
B Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.
Cochrane Review The Cochrane database of systematic reviews PubMed DOI
B Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.
Cochrane Review The Cochrane database of systematic reviews PubMed
C Intravenous immunoglobulin for myasthenia gravis
Systematic Review The Cochrane database of systematic reviews 2003 PubMed
C Impact of Selenium Supplementation in Neutropenia and Immunoglobulin Production in Childhood Cancer Patients
Rct Journal of medicinal food 2016 PubMed DOI
C Breast-Milk Iodine Concentrations and Iodine Levels of Infants According to the Iodine Status of the Country of Residence: A Systematic Review and Meta-Analysis
Meta Analysis Thyroid : official journal of the American Thyroid Association 2018 PubMed DOI
C Retinol-to-Fat Ratio and Retinol Concentration in Human Milk Show Similar Time Trends and Associations with Maternal Factors at the Population Level: A Systematic Review and Meta-Analysis
Meta Analysis Advances in nutrition (Bethesda, Md.) 2018 PubMed DOI
View all evidence for Colostrum →
Compare

Similar Products

Mother's Gift Colostrum
Roex · Capsule
100
Amyloid Benefits
DaVinci Benefits Line · Capsule
100
Amyloid Complete
DaVinci Laboratories · Capsule
100
Colostrum ImmunDefense
Wonder Laboratories · Capsule
100
GALT-immune
Energetix · Capsule
100
View all Colostrum products →
Colostrum research Best Colostrum All Colostrum products More from BIOVEA View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.